Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2004-12-23
2008-12-16
Crane, L. E. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07465715
ABSTRACT:
Individuals suffering from multiple sclerosis may be treated by administration of an A3 adenosine receptor agonist (A3RAg), such as APNEA, AB-MECA, IB-MECA or Cl-IB-MECA. The A3RAg is preferably administered orally with a pharmaceutically acceptable carrier.
REFERENCES:
patent: 5506214 (1996-04-01), Beutler
patent: 5773423 (1998-06-01), Jacobson et al.
patent: 6117878 (2000-09-01), Linden
patent: 6303619 (2001-10-01), Linden
patent: 6762170 (2004-07-01), Chan et al.
patent: 2002/0094974 (2002-07-01), Castelhano et al.
patent: WO 95/11681 (1995-05-01), None
patent: WO 97/33879 (1997-09-01), None
patent: WO 2004/058791 (2004-07-01), None
Gold et al., “Animal Models for Autoimmune Demyelinating Disorders of the Nervous System,” Molecular Medicine Today, 6, 88-91 (Feb. 2000).
Link et al., “Rat Models as Tool to Develop New Immunotherapies,” Immunological Reviews, 184, 117-128 (2001).
Mix et al., “Gene-Expression Profiling of Experimental Autoimmune Encephalitis,” Neurochemical Research, 27(10), 1157-1163 (Oct. 2002).
Siddiqi, S.M. et al., “Search for New Purine- and Ribose-Modified Adenosine Analogues as Selective Agonists and Antagonists at Adenosine Receptors”, J. Med. Chem, (1995), vol. 38, pp. 1174-1188.
Bar Yehuda Sara
Fishman Pnina
Madi Lea
Browdy and Neimark
Can-Fite Biopharma Ltd.
Crane L. E.
LandOfFree
Method for treatment of multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of multiple sclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4035963